Population PK/PD Modeling and Simulation to Predict the Comparative Long-Term Efficacy of Olokizumab in Rheumatoid Arthritis Patients.

Kosinsky Y, Azarov I, Zhudenkov K, Peskov K, Grishin S, Egorova A, Berezovskaya Y, Lemak M, Samsonov M, Feist E

DOI: 10.3390/jcm15197660
Published: 2026 Oct 2
Container: Journal of clinical medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/jcm15197660,
  title = {Population PK/PD Modeling and Simulation to Predict the Comparative Long-Term Efficacy of Olokizumab in Rheumatoid Arthritis Patients.},
  author = {Kosinsky Y and Azarov I and Zhudenkov K and Peskov K and Grishin S and Egorova A and Berezovskaya Y and Lemak M and Samsonov M and Feist E},
  year = {2026},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm15197660},
  url = {https://doi.org/10.3390/jcm15197660}
}

RIS

TY  - JOUR
TI  - Population PK/PD Modeling and Simulation to Predict the Comparative Long-Term Efficacy of Olokizumab in Rheumatoid Arthritis Patients.
AU  - Kosinsky Y
AU  - Azarov I
AU  - Zhudenkov K
AU  - Peskov K
AU  - Grishin S
AU  - Egorova A
AU  - Berezovskaya Y
AU  - Lemak M
AU  - Samsonov M
AU  - Feist E
PY  - 2026
JO  - Journal of clinical medicine
DO  - 10.3390/jcm15197660
UR  - https://doi.org/10.3390/jcm15197660
ER  -

APA

Y, K., I, A., K, Z., K, P., S, G., A, E., Y, B., M, L., M, S., & E, F. (2026). Population PK/PD Modeling and Simulation to Predict the Comparative Long-Term Efficacy of Olokizumab in Rheumatoid Arthritis Patients.. Journal of clinical medicine. https://doi.org/10.3390/jcm15197660

Source records

pubmed · retrieved 2026-11-10T10:05:46.889Z